Article
Prognostic markers in triple-negative breast cancer.
Cancer - 1 Jan 2007
Rakha Emad A, El-Sayed Maysa E, Green Andrew R, Lee Andrew H S, Robertson John F, Ellis Ian O
Abstract excerpt
BACKGROUND: Triple-negative breast cancer (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is a high risk breast cancer that lacks the benefit of specific therapy that targets these proteins. METHODS: In this study, the authors examined a large and well characterized series of invasive breast carcinoma (n = 1944) with a long-term clinical follow-up (median, 56 months) by using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.